Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, September 1999, p. 690-695, Vol. 6, No. 5
International Centre for Diarrhoeal Disease
Research, Bangladesh, GPO Box 128, Dhaka 1000, Bangladesh
Received 25 January 1999/Returned for modification 15 March
1999/Accepted 24 May 1999
A prospective study was conducted with Bangladeshi children with
rotavirus (RV) diarrhea to assess whether nutritional and clinical
parameters, RV serotypes, levels of interleukin-10 (IL-10), tumor
necrosis factor alpha (TNF- Rotavirus (RV) infection is the most
common cause of hospitalization due to diarrhea in Bangladeshi children
below 5 years of age (31) and is associated with
considerable morbidity and mortality. Persistent diarrhea (PD), which
is defined as diarrhea lasting for 14 days or more, is responsible for
30 to 50% of deaths due to diarrheal illness in developing countries
(13). Although RV infection is not considered a significant
risk factor for PD (7, 23), it does cause PD (19)
especially in immunodeficient children (28). The cause(s) of
PD is not well understood; however, one of the risk factors for PD,
identified in children prior to the development of diarrhea, is
decreased cell-mediated immunity (4, 9, 20). It is,
therefore, possible that children who are already immunodeficient will
have an altered immune response to an initial RV infection that may
then lead to PD.
Immunity in RV infection involves both cellular and humoral immune
responses including cytokines. Several cytokines have been detected in
the plasma and stools of children with acute RV infection (15,
21). Also stimulation by RV induces release of interleukin-8 (IL-8), growth-related peptide This study was aimed at assessing whether children with RV infection
have altered levels of IFN- Patient population.
Children, 7 to 24 months of age,
attending the Clinical Research and Service Centre of the International
Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), Dhaka,
Bangladesh, with complaints of watery diarrhea for 6 to 8 days were
initially enrolled. These children were hospitalized until diarrhea
improved. If diarrhea improved within 14 days of onset, children were
classified as having acute diarrhea (AD), but if diarrhea persisted
beyond 14 days, children were classified as having PD. Improvement in
diarrhea was defined as a decrease in stool frequency to
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Immune Response of Children Who Develop Persistent
Diarrhea following Rotavirus Infection
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
), and gamma interferon (IFN-
), and
RV-specific antibody titers in plasma and stool were associated with
the development of persistent diarrhea. Children with watery diarrhea
for 6 to 8 days, selected from the Dhaka Hospital of the International
Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), were
enrolled in the study and monitored until diarrhea improved. Children
were classified as having acute diarrhea (AD) if diarrhea resolved
within 14 days of onset and as having persistent diarrhea (PD) if
diarrhea persisted for more than 14 days after onset. Uninfected,
control children (n = 13) from the Nutrition Follow-Up
Unit of ICDDR,B were also enrolled. Of the 149 children with diarrhea
enrolled, 29 had diarrhea with RV alone, of which 19 had AD and 10 developed PD. Samples of stool and blood were collected from all
children on enrollment. Stool samples were collected again from
children when they developed PD. Of the 10 children who had an initial
RV infection and then developed PD, only one had persistent RV
infection. Plasma levels of IL-10 and TNF-
were higher in children
with diarrhea compared to uninfected controls but were similar in
children with AD and PD. Plasma IFN-
levels were higher in children
who developed PD than in those with AD (P = 0.008) or
uninfected controls (P = 0.001). In stools, the levels
of TNF-
, the only cytokine detected, were similar in the three
groups of children. RV-specific immunoglobulin G (IgG) titers in plasma
were higher in uninfected children than in those with AD
(P < 0.001) or PD (P = 0.024) but
titers were similar in children with AD and PD. RV-specific IgA titers
in plasma and stool were similar in the three groups of children. From
all observed parameters, only elevated plasma IFN-
levels were
associated with subsequent development of PD. However, a larger sample
size is necessary to substantiate this observation.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
, and RANTES from epithelial cells (11) and IL-2 and gamma interferon (IFN-
) from
lymphocytes (35). It has further been shown that IFN-
and
IL-1 inhibit RV entry into human intestinal cell lines (5).
Thus, cytokines play a key role in RV infection so that alterations in
these cytokines may affect recovery from RV infection. The role of
RV-specific immunoglobulins (Ig) in protection from RV infection is
controversial. Various studies of natural RV infection or of volunteers
challenged with RV have shown that antibodies may be associated with
protection but antibodies do not consistently confer protection from
infection or illness (6, 8, 12, 14, 18, 24, 33).
, IL-10, tumor necrosis factor alpha
(TNF-
), and RV-specific antibodies in plasma and stool, before the
onset of PD. These cytokines were selected on the basis of their
possible antiviral activities (27) and effects on
immunoglobulin A (IgA) secretion (25). Cytokine levels and
RV-specific antibody titers were compared in three groups of children
as follows: (i) children with RV infection for 6 to 8 days who
recovered within 14 days of onset of diarrhea, (ii) children with RV
infection for 6 to 8 days in whom diarrhea persisted for more than 14 days after onset, and (iii) uninfected, control children. Also, since malnutrition and cell-mediated immunity have been shown to be independent risk factors for the development of PD (4), the nutritional status and the general immune responses of the three groups
of children were compared.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
5 in 24 h and/or change of stool consistency from liquid or loose stools to
soft stools. Uninfected, control children were enrolled from the
Nutrition Follow-Up Unit of ICDDR,B. This unit is an outpatient unit
responsible for nutritional rehabilitation and growth monitoring of
children. The children who attend this unit are those who initially
attend the Clinical Research and Service Centre of ICDDR,B with severe malnutrition and diarrhea. Children were included as uninfected controls only if they were 7 to 24 months of age and without any apparent infection for at least 1 month.
Collection and storage of samples.
Samples of stool and
venous blood (7 ml) were collected from all diarrheal children on
enrollment, i.e., at 6 to 8 days after onset of diarrhea. Four
milliliters of blood was collected aseptically in sterile heparinized
Vacutainer tubes (Becton Dickinson, Rutherford, N.J.), 2 ml of blood
was collected in EDTA-containing Vacutainer tubes (Becton Dickinson),
and 1 ml of blood was collected in sterile glass vials. Fresh blood
collected in heparinized Vacutainer tubes was separated on
Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) by centrifugation at
500 × g for 25 min. Peripheral blood mononuclear cells
(PBMs), which formed a band at the interface, were collected, washed,
and counted. Separation of plasma (for estimation of cytokines) and
serum from fresh blood collected in EDTA-containing Vacutainer tubes
and glass vials, respectively, was done by centrifugation for 10 min.
Plasma and serum were stored in aliquots at
70 and
20°C,
respectively, until assayed. Neat stool was stored at
20°C for RV
typing. Stool extracts, for the estimation of cytokines, were prepared
and stored as described before (2).
Assays to determine general immune response. The proliferative response of PBMs was assessed on resting cells by measuring spontaneous DNA synthesis as described previously (3). Results were expressed as counts per minute.
Delayed-type hypersensitivity (DTH) responses were measured by skin tests with the Multitest CMI kit (Pasteur MÉRIEUX, Lyon, France) whereby seven antigens and a glycerin control solution were injected into the skin of the paravertebral area of the back of each child and the induration measured at the end of 48 h. An induration of 2 mm or more was considered to be a positive response. The antigens present in the kit include tetanus (550,000 Mérieux units/ml), diphtheria (1,100,000 Mérieux units/ml), Streptococcus sp. (group C) (2,000 Mérieux units/ml), tuberculin (300,000 IU/ml), Candida albicans (2,000 Mérieux units/ml), Trichophyton mentagrophytes (150 Mérieux units/ml), and Proteus mirabilis (150 Mérieux units/ml). The test was done only on those children who had been immunized against diphtheria, tetanus, and tuberculosis.Laboratory assays to determine nutritional status. Transferrin was measured in plasma by turbidimetry in a discrete analyzer (COBAS-BIO, Roche) using a transferrin kit (Boehringer Mannheim, Mannheim, Germany). Results were expressed as milligrams per deciliter and calculated by interpolation from a standard curve by using human serum standards ranging from 59 to 426 mg/dl (Boehringer Mannheim). Controls used included a serum protein, which was provided in the kit, and in addition, samples were arbitrarily spiked with commercially available serum of known transferrin concentration. The coefficient of variation was 4 to 8%.
Albumin was measured in serum with a photometric calorimetric test kit (ALBUMIN liquicolor; Human Diagnostics, Wiesbaden, Germany) and results expressed as grams per liter.Determination of RV-specific IgA and IgG. Flat-bottomed 96-well microtiter plates (MAXISORP, Nunc, Roskilde, Denmark) were coated with rabbit anti-RV serum diluted 1:5,000 in carbonate buffer (pH 9.6) for 3 h at 37°C. After washing, simian RV (SA11), as a standardized dilution (1:1) of the culture supernatant from MA104 cells, in 1% skimmed milk powder (SMP) in phosphate-buffered saline (PBS, pH 7.2)-Tween (PBST) was added, and the mixture was incubated overnight at 4°C. After washing and blocking with 1% SMP-PBST for 1 h at 37°C, samples of stool or plasma, diluted 1:100 in 1% SMP-PBST, were added in threefold dilutions and incubated for 1 h at 37°C. After washing, 100 µl of goat anti-human IgA or IgG conjugated to horseradish peroxidase (Jackson ImmunoResearch, West Grove, Pa.) diluted 1:500 or 1:4,000, respectively, in 1% SMP-PBST was added to each well for 1 h at 37°C. After washing, 100 µl/well of the substrate 3,3',5,5',-teramethyl benzidine (TMB; Sigma Chemical Co., St. Louis, Mo.) was added for 10 min, after which point the reaction was stopped with 1 M sulfuric acid. The optical density was read at 450 nm in a spectrophotometer (Titertek Multiskan Plus). Background wells included those where MA104 cells were added instead of SA11 and those where no samples were added. A positive control sample of pooled sera of known titer of RV-specific IgA or IgG was always included. Endpoint titers were calculated as a reciprocal of the interpolated dilution of the sample giving an optical density 0.1 above the background. Calculations were carried out by using a computer-based program (Multi; Data Tree Inc., Wathams, Mass.). Results were expressed as specific titer of IgA or IgG.
Determination of cytokine levels. IL-10 was measured in plasma and fecal extracts with an ELISA kit (Endogen Inc., Boston, Mass.) which was capable of detecting <3 pg of human IL-10 per ml of sample. Assays were done in duplicate. Concentrations were calculated by interpolation from a standard curve and were expressed as picograms per milliliter of plasma or picograms per gram of stool.
TNF-
was measured by using the DuoSet ELISA Development System
(Genzyme Diagnostics, Cambridge, Mass.), and the lowest detection limit
was 5.8 pg of TNF-
per ml of sample. Concentrations were calculated
by interpolation from a standard curve and were expressed as picograms
per milliliter of plasma or picograms per gram of stool.
IFN-
was measured with an ELISA as described earlier
(26), and the detection limit for IFN-
was 110 pg/ml.
Briefly, flat-bottomed 96-well microtiter plates (MAXISORP) were coated
overnight at 4°C with a monoclonal antibody (MAb) to human IFN-
(Chromogenix AB, Molndal, Sweden) at a concentration of 2 µg/ml in
PBS. After washing and blocking, undiluted samples and standard
recombinant IFN-
(R&D, Abingdon, United Kingdom) were added at
doubling dilutions from 6,000 to 187.5 pg/ml in PBST containing 0.1%
bovine serum albumin (BSA) (Sigma). Standards and samples were added in
duplicate, and the mixtures were incubated overnight at 4°C. After
washing, biotinylated MAb to human IFN-
(Chromogenix) was added at
1:200 in PBST containing 0.1% BSA for 3 h at room temperature.
ExtrAvidin horseradish peroxidase (Sigma) was then added to each well,
and the mixtures were incubated at room temperature for 1 h. The
substrate, ortho-phenylenediamine dihydrochloride (OPD)
(Sigma) at a concentration of 1 mg/ml in 0.1 M citrate buffer (pH
4.5)-0.01% hydrogen peroxide (Sigma), was added for 20 min. The
optical density was then measured at 450 nm in a spectrophotometer
(Titertek Multiskan Plus). Positive and negative control samples were
included in all assays and consisted of pooled supernatants from PBMs
collected from healthy individuals and stimulated with
phytohemagglutinin (Murex Diagnostics Ltd., Dartford, United Kingdom)
(for positive control) or from unstimulated PBMs (for negative control)
of known IFN-
concentration. Concentrations were calculated by
interpolation from a standard curve and were expressed as picograms per
milliliter of plasma or picograms per gram of stool.
Statistical analysis.
Comparisons among the three groups of
children were done with the Kruskal-Wallis test (for nonparametric
data) or one-way analysis of variance (for parametric data).
Comparisons between two groups were done by using the Mann-Whitney U
test (for nonparametric data) or the t test (for parametric
data). For comparisons between proportions, the chi-square statistic
was used. Multiple regression analysis was carried out to determine the
effects of age, nutritional status, sex, and concomitant infection on
plasma levels of IFN-
. Differences were considered to be significant
when P was
0.05. Data analyses were carried out by using
the Statistical Package for Social Sciences (version 7.5 for Windows;
SPSS Inc., Chicago, Ill.).
| |
RESULTS |
|---|
|
|
|---|
Patient characteristics.
A total of 149 children with watery
diarrhea were enrolled, of whom 108 had AD and 41 developed PD. Of
these children, 29 were included who had diarrhea due to RV alone,
without other enteropathogens. Of the 29 children with RV infection, 19 had AD and 10 developed PD. The clinical characteristics of the
children are shown in Table 1. Children
who developed PD were younger than uninfected children (P = 0.008) but were similar in age to children with AD. The frequency
of passage of stool and vomiting on enrollment (Table 1) and the extent
of dehydration (data not shown) were similar in children with AD and in
those who developed PD. From children who developed PD, stool samples
were collected again approximately 1 week later, i.e., when they
developed PD, and tested for the presence of enteropathogens. Out of
these 10 children with PD, RV was detected in 1, EPEC alone was
detected in 1, EPEC with Aeromonas sp. was detected in 1, ETEC was detected in 2, EAEC was detected in 2 and
Salmonella sp. was detected in 1. No pathogens were detected
in two children. The clinical course of the 10 children who developed
PD was varied, and after enrollment, they were hospitalized for a
median of 13.5 days (range, 8 to 29 days).
|
Nutritional status. The nutritional statuses (Table 1), as determined by weight-for-age as a percentage of the National Center for Health Statistics median and serum albumin and plasma transferrin concentrations, were similar in all three groups of children.
General immune response. Spontaneous proliferation was significantly different among the three groups of children (P = 0.013). PBMs from children with AD showed significantly higher spontaneous proliferation (median, 3,785 cpm; 25th to 75th quartiles, 1,627 to 5,767 cpm) than those from uninfected children (median, 984 cpm; 25th to 75th quartiles, 517 to 2,256 cpm; P = 0.005). PBMs from children who developed PD had a proliferative response (median, 2,364 cpm; 25th to 75th quartiles, 1,062 to 3,298 cpm) that was similar to those with AD and those of uninfected children. DTH responses were compared on the basis of the number of children who had a positive response to at least one antigen. The three groups of children were similar with at least one antigen positive in 11 of 12 uninfected children, 13 of 17 children with AD, and in 5 of 7 children who developed PD.
RV-specific antibodies in plasma and stool.
Titers of
RV-specific IgA in the plasma and stool were similar in the three
groups of children (Table 2). RV-specific
IgG titers (Table 2) were significantly different among the three groups of children (P = 0.002) with titers being higher
in uninfected children than in those with AD (P < 0.001) or those who developed PD (P = 0.024);
titers were similar in children with AD and those who developed PD.
|
Cytokine levels in plasma and stool.
On enrollment, plasma
levels of IL-10 (Fig. 1A), TNF-
(Fig.
1B), and IFN-
(Fig. 1C) were significantly different among the three
groups of children (P = 0.001, 0.021, and 0.001, respectively). Compared to uninfected children, children with RV
infection, whether with AD or PD, had higher plasma levels of IL-10
(P < 0.001 and 0.026, respectively) and TNF-
(P = 0.022 and 0.013, respectively). IL-10 and TNF-
levels in the plasma were similar in children with AD and those who
developed PD. IFN-
levels in the plasma (Fig. 1C) were higher in
children who developed PD than in uninfected children (P = 0.001) or those with AD (P = 0.008); there was no difference in levels between children with AD and uninfected controls. In order to assess whether differences in plasma IFN-
levels were
significant due to higher values in two children who developed PD (Fig.
1C), comparisons were repeated without these two outliers. Such
comparisons showed that significant differences in IFN-
levels in
the plasma remained when the three groups were compared (P = 0.008) and when children with AD and those who developed PD were
compared (median, 1,151 pg/ml; 25th to 75th quartiles, 1,032 to 1393 pg/ml; P = 0.038).
|
were not detectable in the three
groups of children. Although TNF-
was detectable in the stools, levels were similar in the three groups of children (data not shown).
Effects of other factors on IFN-
levels in the plasma.
As
other factors such as age, nutritional status, sex, and concomitant
infections could have an influence on IFN-
levels, multiple
regression analysis was carried out to assess their effects on plasma
IFN-
levels. None of the variables tested had a significant effect.
G and P types of RV strains.
Stool samples from 19 children
with diarrhea (AD, n = 13; PD, n = 6)
were available for typing RV strains. No PAGE pattern was obtained from
nine samples, suggestive of a low concentration of virus particles in
stool, and these samples were, therefore, not typed. RV strains from
seven children with AD and three children who developed PD were typed,
and the results are shown in Table 3. The
overall frequency of the strain types observed is similar to that found
in the community (32), and there were too few strains to
ascertain differences between children with AD and those who developed
PD.
|
| |
DISCUSSION |
|---|
|
|
|---|
The immune response in PD due to a defined etiology has not been investigated before. For this purpose, children with a 6- to 8-day history of diarrhea from RV infection were studied. The high percentage of PD from an initial RV infection observed here (10 of 29) could be because children who already had prolonged RV infection were selected. Children with a diarrhea duration of 6 to 8 days were chosen on the basis that a reasonable number would develop PD. Enrollment of children at a more acute stage of diarrhea would result in too large a sample size for the study to be manageable.
Of the 10 children who developed PD, only one was found to have persistent RV infection when second samples of stools were tested for enteropathogens at 15 to 18 days after the onset of diarrhea. This data suggests that PD from an initial RV infection is not due to persistence of RV but to an alteration in some host factor(s) which makes the children more susceptible to other infections or which leads to prolonged malabsorption. Other studies have also shown that PD is often due to sequential infection by different organisms rather than by a single organism (10). Our finding that children with AD and those who developed PD cannot be differentiated clinically during the acute stage of illness corroborates previous findings, which showed that clinical characteristics have a low positive predictive value for the development of PD (22).
In contrast to earlier studies (4, 9, 20) we found that the general immune responses of children were not lower in those who developed PD. Comparisons between the present study and previous studies on the role of the immune response in the development of PD is difficult as our study was conducted with children who already had diarrhea for 6 to 8 days while previous studies were conducted with children prior to the development of diarrhea. In this study, children who developed PD were not significantly malnourished, which is in contrast to an earlier study where malnutrition during AD was found to be a risk factor for the development of PD (23). It is possible that when specific etiologies are considered, the overall risk factors are different. Thus, it has been shown that RV infection occurs more commonly in better-nourished children (31) so that PD from RV infection also may not be related to malnutrition.
The role of RV-specific antibodies in protection against RV infection and illness is controversial (6, 8, 12, 14, 18, 24, 33). RV-specific IgG in serum correlates negatively with illness from RV (14), and this corroborates our finding of higher titers of RV-specific IgG in the plasma of uninfected children than in diarrheal children (both AD and PD). The results from this study suggest that RV-specific IgG or IgA has no role in the development of PD following an initial RV infection. However, a larger sample size is required to confirm this.
The role of IL-10 in RV infection has not been investigated, and the
significance of our finding that IL-10 levels in the plasma are
increased in children with RV infection (whether AD or PD) is not
clear. As IL-10 promotes B-cell proliferation and IgA secretion
(25) we hypothesized that in RV infection IL-10 could have a
beneficial effect by stimulating the secretion of RV-specific IgA.
However, as IL-10 levels were not different between children with AD
and those who developed PD, it is unlikely that IL-10 is important in
protection against prolonged diarrhea or as a marker of disease
severity. TNF-
is an antiviral cytokine (27). The
increased levels observed during the first week of RV infection
(whether in AD or PD) may reflect antiviral activity. However, as there
is no association between the development of PD and plasma levels of
TNF-
, the relevance of TNF-
levels in plasma to the resolution of
diarrhea from RV remains unclear.
IFN-
is produced by human PBMs stimulated with RV (35),
and IFN-
can inhibit entry of RV into cultured epithelial cells (5). In contrast, clearance of RV by CD8+ T cells appears
not to be dependent on IFN-
(17). Thus the role of
IFN-
in RV infection is not clear. In the present study, children
with AD and uninfected children had similar levels of IFN-
, while
children who developed PD had higher plasma IFN-
levels than those
with AD or uninfected children. The implications of these findings are
not clear but they suggest that (i) IFN-
has no role in protection against prolonged diarrhea following RV infection, (ii) IFN-
is a
correlate of a more serious pathology, and/or (iii) elevated levels of
IFN-
during the acute stage of RV infection are detrimental. IFN-
can stimulate the immune response such that it leads to lysis of
bystander cells, thereby causing more tissue damage (29). Furthermore, products of IFN-
-induced cell lysis may cause
inflammation of tissue, as has been shown for lymphocytic
choriomeningitis virus infection (29). As in this study PD
following an initial RV infection was not due to persistence of RV, it
is possible that another factor, such as enhanced inflammation during
the acute stage of the infection, could have led to prolonged diarrhea. However, we have no evidence to support this hypothesis.
In summary, the results of the present study show that during acute RV
infection, IL-10 and TNF-
are elevated in the plasma and the
development of PD is associated with a higher IFN-
response. However, a larger sample size is required to confirm these trends.
| |
ACKNOWLEDGMENTS |
|---|
This research was supported by the ICDDR,B Centre for Health and Population Research and USAID under cooperative agreement #DPE-5986-A-00-1009-00.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Laboratory Sciences Division, ICDDR,B, GPO Box 128, Dhaka 1000, Bangladesh. Phone: 880 2 871751. Fax: 880 2 883116. E-mail: tasnim{at}icddrb.org.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Albert, M. J., S. M. Faruque, A. S. G. Faruque, P. K. B. Neogi, M. Ansaruzzaman, N. A. Bhuiyan, K. Alam, and M. S. Akbar. 1995. A controlled study of Escherichia coli diarrheal infections in Bangladeshi children. J. Clin. Microbiol. 33:973-977[Abstract]. |
| 2. | Azim, T., R. C. Halder, M. S. Sarker, S. Ahmed, J. Hamadani, A. Chowdhury, F. Qadri, M. A. Salam, R. B. Sack, and M. J. Albert. 1995. Cytokines in the stools of children with complicated shigellosis. Clin. Diagn. Lab. Immunol. 2:492-495[Abstract]. |
| 3. | Azim, T., M. S. Sarker, J. Hamadani, N. Khanum, R. C. Halder, M. A. Salam, and M. J. Albert. 1996. Alterations in lymphocyte phenotype and function in children who develop complications in shigellosis. Clin. Diagn. Lab. Immunol. 3:191-196[Abstract]. |
| 4. |
Baqui, A. H.,
R. E. Black,
R. B. Sack,
H. R. Chowdhury,
M. Yunus, and A. K. Siddique.
1993.
Malnutrition, cell mediated immune deficiency, and diarrhea: a community-based longitudinal study in rural Bangladeshi children.
Am. J. Epidemiol.
137:355-365 |
| 5. | Bass, D. M. 1997. Interferon gamma and interleukin 1, but not interferon alfa, inhibit rotavirus entry into human intestinal cell lines. Gastroenterology 113:81-89[Medline]. |
| 6. | Bernstein, D. I., D. S. Sander, V. E. Smith, M. S. Gilbert, and R. L. Ward. 1991. Protection from rotavirus reinfection: a 2 year prospective study. J. Infect. Dis. 164:277-283[Medline]. |
| 7. | Bhardwaj, A., V. Aggarwal, A. Chakravarty, and S. K. Mittal. 1996. Does rotavirus infection cause persistent diarrhoea in childhood? Trop. Gastroenterol. 17:18-21[Medline]. |
| 8. | Black, R. E., H. B. Greenberg, A. Z. Kapikian, K. H. Brown, and S. Becker. 1982. Acquisition of serum antibody to Norwalk virus and rotavirus and relation to diarrhea in a longitudinal study of young children in rural Bangladesh. J. Infect. Dis. 145:483-489[Medline]. |
| 9. | Black, R. E., C. F. Lanata, and F. Lazo. 1989. Delayed cutaneous hypersensitivity: epidemiologic factors affecting and usefulness in predicting diarrheal incidence in young Peruvian children. Pediatr. Infect. Dis. J. 8:210-215[Medline]. |
| 10. | Black, R. E. 1993. Persistent diarrhea in children of developing countries. Pediatr. Infect. Dis. J. 12:751-761[Medline]. |
| 11. | Casola, A., M. K. Estes, S. E. Crawford, P. L. Ogra, P. B. Ernst, R. P. Garofalo, and S. E. Crowe. 1998. Rotavirus infection of cultured intestinal epithelial cells induces secretion of CXC and CC chemokines. Gastroenterology 114:947-955[Medline]. |
| 12. | Chiba, S., T. Yokoyama, S. Nakata, Y. Morita, T. Urasawa, K. Taniguchi, S. Urasawa, and T. Nakao. 1986. Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet ii:417-421. |
| 13. | Child Health Research Project. 1997. Synopsis: persistent diarrhea algorithm, no. 1. U.S. AID, Washington, D.C. |
| 14. | Clemens, J. D., R. L. Ward, M. R. Rao, D. A. Sack, D. R. Knowlton, F. P. L. van Loon, S. Huda, M. McNeal, F. Ahmed, and G. Schiff. 1992. Seroepidemiologic evaluation of antibodies to rotavirus as correlates of the risk of clinically significant rotavirus diarrhea in rural Bangladesh. J. Infect. Dis. 165:161-165[Medline]. |
| 15. |
De Boissieu, D.,
P. Lebon,
J. Badoual,
Y. Bompard, and C. Dupont.
1992.
Rotavirus induces -interferon release in children with gastroenteritis.
J. Pediatr. Gastroenterol. Nutr.
16:29-32.
|
| 16. | Faruque, S. M., K. Haider, M. J. Albert, Q. S. Ahmad, S. Nahar, and S. Tzipori. 1992. A comparative study of specific gene probes and standard bioassays to identify diarrhoeagenic Escherichia coli in paediatric patients with diarrhoea in Bangladesh. J. Med. Microbiol. 36:37-40[Abstract]. |
| 17. | Franco, M. A., C. Tin, L. S. Rott, J. L. VanCott, J. R. McGhee, and H. B. Greenberg. 1997. Evidence for CD8+ T-cell immunity to murine rotavirus in the absence of perforin, fas, and gamma interferon. J. Virol. 71:479-486[Abstract]. |
| 18. | Kapikian, A. Z., R. G. Wyatt, M. M. Levine, R. H. Yolken, D. H. VanKirk, R. Dolin, H. B. Greenberg, and R. M. Chanock. 1983. Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance. J. Infect. Dis. 147:95-106[Medline]. |
| 19. | Khoshoo, V., M. K. Bhan, S. Jayashree, and R. Kumar. 1990. Rotavirus infection and persistent diarrhoea in young children. Lancet 336:1314-1315[Medline]. |
| 20. |
Koster, F. T.,
D. L. Palmer,
J. Chakraborty,
T. Jackson, and G. C. Curlin.
1987.
Cellular immune competence and diarrheal morbidity in malnourished Bangladeshi children: a prospective field study.
Am. J. Clin. Nutr.
46:115-120 |
| 21. |
Kutukeuler, N., and S. Caglayan.
1997.
Tumor necrosis factor- and interleukin-6 in stools of children with bacterial and viral gastroenteritis.
J. Pediatr. Gastroenterol. Nutr.
25:556-558[Medline].
|
| 22. | Lanata, C. F., R. E. Black, R. H. Gilman, F. Lazo, and R. D. Aguila. 1991. Epidemiologic, clinical, and laboratory characteristics of acute vs. persistent diarrhea in periurban Lima, Peru. J. Pediatr. Gastroenterol. Nutr. 12:82-88[Medline]. |
| 23. |
Mahalanabis, D.,
A. N. Alam,
N. Rahman, and A. Hasnat.
1991.
Prognostic indicators and risk factors for increased duration of acute diarrhoea and for persistent diarrhoea in children.
Int. J. Epidemiol.
20:1064-1072 |
| 24. | Matson, D. O., M. L. O'Ryan, I. Herrera, L. K. Pickering, and M. K. Estes. 1993. Fecal antibody responses to symptomatic and asymptomatic rotavirus infections. J. Infect. Dis. 167:577-583[Medline]. |
| 25. | Moore, K. W., A. O'Garra, R. de W. Malefyt, P. Viera, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165-190[Medline]. |
| 26. |
Quiding, M.,
I. Nordstrom,
A. Kilander,
G. Andersson,
L. A. Hanson,
J. Holmgren, and C. Czerkinsky.
1991.
Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon- production and evokes local immunological memory.
J. Clin. Investig.
88:143-148.
|
| 27. | Ramsay, A. J., J. Ruby, and I. A. Ramshaw. 1993. A case for cytokines as effector molecules in the resolution of virus infection. Immunol. Today 14:155-157[Medline]. |
| 28. | Saulsbury, F. T., J. A. Winkelstein, and R. H. Yolken. 1980. Chronic rotavirus infection in immunodeficiency. J. Pediatr. 97:61-65[Medline]. |
| 29. |
Smith, M. J., and J. A. Trapani.
1998.
The relative role of lymphocyte granule exocytosis versus death receptor-mediated cytotoxicity in viral pathophysiology.
J. Virol.
72:1-9 |
| 30. | Unicomb, L. E., F. Bignan, Z. Rahim, N. N. Banu, J. G. Gomes, G. Podder, M. H. Munshi, and S. R. Tzipori. 1993. A one-year survey of rotavirus strains from three locations in Bangladesh. Arch. Virol. 132:201-208[Medline]. |
| 31. | Unicomb, L. E., P. E. Kilgore, A. S. G. Faruque, J. D. Hamadani, G. J. Fuchs, M. J. Albert, and R. I. Glass. 1997. Anticipating rotavirus vaccines: hospital-based surveillance for rotavirus diarrhea and estimates of disease burden in Bangladesh. Pediatr. Infect. Dis. J. 16:947-951[Medline]. |
| 32. |
Unicomb, L. E.,
G. Podder,
J. R. Gentsch,
K. Z. Hasan,
A. S. G. Faruque,
M. J. Albert, and R. I. Glass.
1999.
Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995.
J. Clin. Microbiol.
37:1885-1891 |
| 33. | Ward, R. L., D. I. Bernstein, R. Shukla, E. C. Young, J. R. Sherwood, M. M. McNeal, M. C. Walker, and G. M. Schiff. 1989. Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J. Infect. Dis. 159:79-88[Medline]. |
| 34. | World Health Organization. 1987. Manual for laboratory investigations of acute enteric infections, p. 9-20. World Health Organization, Geneva, Switzerland. |
| 35. | Yasukawa, M., O. Nakagomi, and Y. Kobayashi. 1990. Rotavirus induces proliferative response and augments non-specific cytotoxic activity of lymphocytes in humans. Clin. Exp. Immunol. 80:49-55[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |